Further study of the adhesion molecules and the immunologic response in CCA may provide important insights into the immunobiology of this neoplastic process.

This study addresses the question of whether older patients with gestational trophoblastic neoplasia in the United Kingdom have a worse prognosis and poorer response to chemotherapeutic regimens than younger women.

Magnetic resonance imaging and Doppler ultrasound are complementary investigations of the pelvis in patients with gestational trophoblastic neoplasia; the vascularity of the tumor is better assessed on Doppler ultrasound, and tumor extension and detection are better with magnetic resonance imaging.

It is important that strict histologic criteria for gestational trophoblastic disease are used in the assessment of all samples of tubal ectopic gestation.

This diagnostic score should be very useful for comparing the nearly true incidence of choriocarcinoma and survival rate between nations.

Further study of this relationship between human chorionic gonadotropin as an angiogenic factor in molar pregnancy and persistent gestational trophoblastic neoplasia may provide important new insights into the biology of gestational trophoblastic diseases and may contribute to the development of novel therapies.

In this study, sexual dysfunction was noted to be a common complication of treatment of gestational trophoblastic neoplasia yet was given little attention as compared to other complications.

Gestational trophoblastic neoplasia has varying tendencies toward local invasion and distant metastases because of abnormal growth and proliferation of trophoblastic cells.

In addition to its role in inhibiting tumor adhesion and invasion, TIMP₃ induced apoptosis and inhibited the growth of jeg-3 and bewo.

Surgery remains an important part of the management of selected cases of gestational trophoblastic neoplasia, and predictive markers of chemotherapy resistance need to be identified to allow such patients to be selected early.

We sought to explore the differential protein expression between benign/remitting and malignant-transformed hydatidiform mole, searching for a prognostic biomarker to immediately identify those patients requiring chemotherapy to achieve early diagnosis and early intervention.

The traditional presenting signs and symptoms of hydatidiform mole are less frequently present in current patients, especially for severe complications such as pregnancy-induced hypertension and hyperthyroidism.

This study examined intrauterine pathology in patients with post-molar gestational trophoblastic neoplasia and hydatidiform mole after suction curettage and evaluated safety profiles of endometrial sampling in this setting.

No correlation was found between the fetal outcome and the amount of chemotherapeutic exposure.

Free hCGbeta-subunit proportion of total hCG measurement can help distinguish placental site trophoblastic tumor from more common forms of gestational trophoblastic disease.